PMVP icon

PMV Pharmaceuticals
PMVP

Overview Fund Activity

70 hedge funds and large institutions have $58.8M invested in PMV Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 31 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
70
Holders Change
-4
Holders Change %
-5.41%
% of All Funds
0.93%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
6
Increased
15
Reduced
31
Closed
10
Calls
$115K
Puts
$19K
Net Calls
+$96K
Net Calls Change
+$96K

Top Buyers

1
BCM
1
BML Capital Management
Indiana
$5.23M
2
SCM
2
Stonepine Capital Management
Oregon
$809K
3
SCM
3
Sio Capital Management
New York
$5.39M
4
UBS Group
4
UBS Group
Switzerland
$416K
5
PHS
5
PFM Health Sciences
California
$3.14M

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$163K
2
PCS
2
Personal CFO Solutions
New Jersey
$0
3
AI
3
Acuitas Investments
Washington
$0
4
Goldman Sachs
4
Goldman Sachs
New York
$183K
5
Assenagon Asset Management
5
Assenagon Asset Management
Luxembourg
$232K
Name Holding Trade Value Shares
Change 		Shares
Change %
Qube Research & Technologies (QRT)
76
Qube Research & Technologies (QRT)
United Kingdom
– -$39.1K -26,257 Closed
Amundi
77
Amundi
France
– -$38.9K -26,182 Closed
HP
78
Harbourvest Partners
Massachusetts
– -$17.2K -11,533 Closed
CFM
79
Catalyst Funds Management
Australia
– -$3.13K -2,100 Closed
NA
80
Nordwand Advisors
Pennsylvania
– -$2.98K -2,000 Closed
1 2 3
4